|
Site Map |
|
OUR STRATEGY
MetaCyte is essentially a health science start-up manufacturing company.
The MetaCyte team proactively searches for raw material - technology and ideas from health science professionals - and turns that raw material into products - health science start-ups.
The products are developed with MetaCyte's customers - professional investors in health science companies - in mind.
MetaCyte gets involved with its ventures very early; often there is just a promising idea or technology and a desire to do something useful with it. That's where the partnership begins.
Steve Gailar, MetaCyte President and CEO , has said that there is no single formula for health science commercialization success - each inventor and idea has a distinctive starting point, target market and potential.
However, all MetaCyte companies have one trait in common - milestone-driven development pathways.
The MetaCyte team works to create a unique milestone-driven development pathway for each portfolio company; a clear set of development objectives designed to advance translational research rapidly from discovery to a proof-of-concept development stage that will support further financing.
In certain unique situations, MetaCyte will work with an early stage operating company, providing critical capabilities that facilitate the next stage of development or funding. In these cases, MetaCyte tailors a defined service agreement to insure needed support - general or operational management - as well as planning is delivered to achieve the anticipated milestone.
|
|
|
From the Mind to the Marketplace.
|
|
|
 |
Copyright © 2008 MetaCyte Business Lab LLC. All rights reserved. |
Privacy Policy |
Site Map
|
